1. Document reveals scope of Operation Warp Speed and underscores vast military involvement — New data bolsters Sarepta gene therapies for two deadly muscle diseases — Inovio forced to delay planned phase 2/3 testing of COVID vaccine — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Merck, Pfizer need to jettison consumer health units before the market deteriorates

Discussion in 'Merck' started by anonymous, Apr 16, 2018 at 11:00 AM.

  1. anonymous

    anonymous Guest

    Both Pfizer and Merck planned to dispose their consumer health businesses since they failed to return profits, dampening their efforts to innovate in other segments. However, bidders eventually lost interest in Merck’s consumer health line, even as the auction of Pfizer’s consumer health unit gained traction.
    But the latest reports suggest that Merck and Mylan are engaged in talks with regards to the transfer of the consumer health business. https://news.alphastreet.com/merck-...-health-units-before-the-market-deteriorates/
     

  2. anonymous

    anonymous Guest

    Wrong Merck. Sold consumer health to Bayer years ago.